Hyaluronic acid products market thrives on rising demand for minimally-invasive surgeries
The global hyaluronic acid products market is projected to grow from US$5.32 billion in 2012 to US$9.85 billion by 2019, according to a market report published by Transparency Market Research.
If these values hold true, the report forecasts that the market will grow at a healthy CAGR of 9.2% from 2013 to 2019.The hyaluronic acid products market is largely driven by factors such as increasing demand for anti-ageing procedures, growing geriatric population, rising awareness among patients regarding the side-effects of various products, and surging demand for minimally-invasive surgical procedures.
On the basis of products, the hyaluronic acid products market is segmented into five-injection cycle, three-injection cycle, and single-injection. Given the changing dynamics of the global hyaluronic acid products market and the growing preference for short-duration treatments among patients, the single-injection and three-injection cycle segments are likely to expand over the next four years. Moreover, treatment side-effects include inflammation, redness, and itching, and patients prefer to minimize these by opting for shorter treatment procedures.Hyaluronic acid products find applications in a number of areas including ophthalmic, osteoarthritis, vesicoureteral reflux (VUR), and dermal fillers. Dermal fillers formed the largest segment of the hyaluronic acid products market in 2012, followed by osteoarthritis. The demand for hyaluronic acid products for the treatment of VUR has grown over the years and this demand is likely to develop at a strong CAGR of 12.0% from 2013 to 2019. The main factors fueling the growth of this segment of the hyaluronic acid products market are increasing demand for minimally-invasive procedures, rise in geriatric population, and growing awareness regarding beauty enhancement surgeries.
Geographically, the market for hyaluronic acid products is divided into North America, Europe, Asia Pacific, and Rest of the World. Increased acceptance of premium-priced hyaluronic acid products, high product demand, and increased awareness regarding modern treatments has made North America the largest regional market for hyaluronic acid products. Even with the crippling effects of an economic downturn, Europe is the second largest market. Asia Pacific and RoW, however, have been identified as having the most potential for growth over the remainder of the forecast period owing to increasing demand for minimally-invasive surgeries, improvement in healthcare infrastructure, and rapid economic development.
The prominent players operating in the global hyaluronic acid products market include Alcon, Inc., Meiji Seika Pharma Co., Ltd., Zimmer Holdings, Inc., Allegran Inc., Galderma S.A., Sanofi (Genzyme), Anika Therapeutics, Inc., Salix Pharmaceuticals, Inc., Seikagaku Corporation, Smith & Nephew plc., F. Hoffmann-La Roche Ltd., Merz Aesthetics, Inc., and Ferring Pharmaceuticals, Inc.
You can access the report Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 by visiting http://www.transparencymarketresearch.com/hyaluronic-acid-products-market.html
